Last 48 quarters of trend data · Healthcare · Medical - Devices
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 12.50 | — | — | 490.00 | 18.43 | 7.73 | 293.75 | — | — | — | — | — | 4.04 | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 0.39 | 0.64 | 1.01 | 0.91 | 0.72 | 0.78 | 0.51 | 0.49 | 0.82 | 0.69 | 1.37 | 1.31 | 1.49 | 1.25 | 0.97 | 1.17 | 1.16 | 0.74 | 1.14 | 0.87 | 1.75 |
| — | -17.3% | +96.4% | +86.6% | -11.3% | +13.1% | -62.5% | -62.6% | -45.2% | -45.2% | +41.3% | +11.6% | +28.5% | +68.6% | -15.4% | +34.2% | -33.6% | -68.5% | -70.1% | +95.9% | +799.0% | |
| P/B Ratio | 1.10 | 1.48 | 1.73 | 2.32 | 1.91 | 2.26 | 1.54 | 1.43 | 2.00 | 1.82 | 3.19 | 2.86 | 2.73 | 3.27 | 2.12 | 2.09 | 2.05 | 1.61 | 2.02 | 1.58 | 2.95 |
| — | -34.8% | +12.5% | +61.6% | -4.2% | +24.1% | -51.9% | -49.9% | -26.8% | -44.2% | +50.5% | +36.7% | +33.2% | +102.9% | +4.8% | +32.6% | -30.6% | -61.4% | -64.8% | -8.2% | — | |
| P/FCF | 5.17 | — | — | 5.92 | 5.76 | 30.16 | 193.58 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | 5.14 | — | — | 37.04 | 8.00 | 6.04 | 11.30 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | 8.82 | — | — | 13.99 | 12.00 | 7.28 | 22.41 | — | — | — | — | — | 5.32 | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 62.9% | 57.9% | 57.3% | 54.9% | 66.1% | 68.6% | 61.5% | 50.8% | 58.4% | 62.1% | 62.1% | 61.0% | 61.3% | 61.6% | 58.7% | 54.4% | 54.6% | 54.8% | 58.3% | 55.1% | 52.2% |
| — | -15.6% | -6.8% | +7.9% | +13.3% | +10.5% | -0.9% | -16.6% | -4.8% | +0.8% | +5.7% | +12.1% | +12.3% | +12.3% | +0.7% | -1.2% | +4.6% | -13.7% | -9.6% | -14.1% | -20.9% | |
| Operating Margin | 5.4% | -39.8% | -14.0% | -2.9% | 7.6% | 13.1% | 3.2% | -6.0% | -13.5% | -9.8% | -12.4% | -13.5% | -13.5% | -6.9% | -8.8% | -11.3% | -13.1% | -8.5% | -14.1% | -13.7% | -10.5% |
| — | -404.9% | -533.2% | +51.1% | +156.5% | +232.7% | +126.0% | +55.9% | +0.1% | -43.1% | -41.7% | -19.9% | -3.0% | +19.2% | +37.8% | +17.5% | -25.3% | -159.5% | -35311.5% | -898.8% | -293.4% | |
| Net Margin | 3.7% | -40.9% | -14.8% | 0.2% | 3.9% | 10.0% | 0.2% | -10.0% | -18.0% | -12.9% | -15.8% | -15.3% | 36.9% | -10.8% | -11.6% | -14.5% | -16.3% | -11.2% | -17.1% | -16.3% | -13.1% |
| — | -507.7% | -8489.8% | +101.8% | +121.9% | +177.7% | +101.1% | +34.4% | -148.7% | -19.1% | -36.3% | -5.8% | +326.8% | +3.3% | +32.2% | +11.5% | -24.3% | -128.7% | -7286.2% | -224.4% | -34.9% |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 10.6% | -21.2% | -6.2% | 0.1% | 2.6% | 7.7% | 0.1% | -7.1% | -11.1% | -8.3% | -8.9% | -8.1% | 21.6% | -6.9% | -6.2% | -6.6% | -7.7% | -6.0% | -7.4% | -7.2% | -5.4% |
| — | -376.4% | -4745.1% | +101.6% | +123.9% | +192.2% | +101.5% | +12.1% | -151.4% | -21.1% | -43.0% | -23.0% | +379.1% | -15.5% | +15.5% | +8.2% | -42.4% | -173.2% | -5974.6% | -47.8% | — | |
| ROA | 5.3% | -11.9% | -3.6% | 0.1% | 1.2% | 3.6% | 0.1% | -3.3% | -5.2% | -4.1% | -4.7% | -4.7% | 11.7% | -3.4% | -3.4% | -3.8% | -4.3% | -3.2% | -4.1% | -4.1% | -3.1% |
| — | -435.2% | -5964.1% | +101.7% | +124.1% | +187.4% | +101.3% | +29.5% | -144.0% | -19.6% | -40.2% | -22.7% | +371.4% | -5.5% | +18.0% | +8.1% | -38.5% | -160.8% | -6987.0% | -145.4% | +3.4% | |
| ROIC | 8.1% | -12.7% | -3.8% | -1.0% | 2.5% | 4.6% | 1.1% | -1.9% | -3.8% | -3.0% | -3.7% | -4.1% | -4.3% | -2.1% | -3.0% | -4.2% | -4.8% | -3.3% | -4.6% | -4.7% | -3.4% |
| — | -378.6% | -448.3% | +45.4% | +166.6% | +251.5% | +129.8% | +53.5% | +11.0% | -43.8% | -25.0% | +2.0% | +11.1% | +36.7% | +36.4% | +10.1% | -39.4% | -191.9% | -39559.0% | -900.9% | -282.1% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.56 | 0.65 | 0.32 | 0.56 | 0.64 | 0.76 | 0.78 | 0.82 | 0.79 | 0.78 | 0.60 | 0.46 | 0.42 | 0.76 | 0.66 | 0.50 | 0.46 | 0.62 | 0.59 | 0.55 | 0.53 |
| — | -15.0% | -59.4% | -31.1% | -18.0% | -1.7% | +29.6% | +78.3% | +86.7% | +2.2% | -8.6% | -8.2% | -7.9% | +22.2% | +11.9% | -8.4% | -13.3% | +17.9% | +5.0% | -57.3% | — | |
| Debt / EBITDA | 2.30 | — | — | 32.82 | 8.78 | 6.40 | 16.05 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 2.65 | 2.16 | 3.34 | 2.65 | 2.21 | 2.47 | 2.34 | 2.35 | 2.12 | 2.44 | 2.34 | 2.82 | 2.92 | 2.33 | 2.12 | 3.24 | 3.97 | 3.57 | 3.81 | 4.00 | 4.38 |
| — | -12.5% | +42.7% | +13.0% | +4.0% | +1.4% | -0.1% | -16.8% | -27.5% | +4.6% | +10.5% | -12.9% | -26.4% | -34.8% | -44.4% | -19.0% | -9.4% | -6.7% | +88.6% | +227.3% | +26.3% | |
| Quick Ratio | 1.63 | 1.05 | 1.64 | 1.63 | 1.06 | 1.16 | 1.03 | 1.00 | 0.88 | 1.01 | 0.98 | 1.22 | 1.36 | 1.13 | 1.05 | 2.10 | 2.48 | 2.18 | 2.27 | 2.38 | 2.49 |
| — | -9.3% | +59.7% | +63.3% | +20.8% | +15.2% | +4.8% | -18.1% | -35.4% | -11.1% | -6.5% | -42.2% | -45.1% | -48.2% | -53.9% | -11.6% | -0.5% | -0.6% | +102.9% | +513.6% | +98.1% | |
| Interest Coverage | 2.91 | -16.23 | -4.11 | 3.23 | 2.73 | 4.79 | 1.03 | -1.77 | -3.14 | -2.86 | -4.19 | -3.56 | 10.12 | -1.77 | -2.59 | -3.42 | -4.32 | -3.27 | -5.10 | -4.10 | -4.39 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying XTNT stock.
Xtant Medical Holdings, Inc.'s current P/E is 12.5x. The average P/E over the last 2 quarters is 254.2x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Xtant Medical Holdings, Inc.'s current operating margin is 5.4%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Xtant Medical Holdings, Inc.'s business trajectory between earnings reports.